Copyright
©The Author(s) 2025.
World J Hepatol. Jun 27, 2025; 17(6): 104761
Published online Jun 27, 2025. doi: 10.4254/wjh.v17.i6.104761
Published online Jun 27, 2025. doi: 10.4254/wjh.v17.i6.104761
Table 1 Classification of portal hypertension
Classification | Etiologies |
Prehepatic | Portal vein thrombosis |
Splenic vein thrombosis | |
Congenital venous abnormalities | |
Intrahepatic | Presinusoidal: Hepatoportal sclerosis; schistosomiasis; myeloproliferative diseases; sarcoidosis; early stage of primary biliary cholangitis; primary sclerosing cholangitis; congenital hepatic fibrosis; arsenic toxicity |
Sinusoidal: Cirrhosis; alcohol-associated hepatitis; nodular regenerative hyperplasia | |
Postsinusoidal: Veno-occlusive disease | |
Posthepatic | Budd-Chiari |
Heart failure | |
Pulmonary hypertension | |
Constrictive pericarditis |
Table 2 Comparison between hepatic vein pressure gradient and endoscopic ultrasound-guided portal pressure gradient
HVPG | EUS-guided portal pressure gradient | |
Technique | Transjugular catheterization of the hepatic vein with a balloon-tipped catheter | Under EUS guidance, fine-needle puncture of the hepatic vein and the portal vein |
Principle | HVPG = wedged hepatic venous pressure – free hepatic venous pressure | PPG = portal vein pressure – hepatic vein pressure |
Sedation | Usually under minimal (low-dose midazolam) or no sedation | Usually under moderate to deep sedation |
Advantages | Well-established as the gold standard for clinically significant portal hypertension assessment | Direct measurement of portal vein pressure. Alternative when HVPG is not accurate such as presinusoidal PH. Can be combined with endoscopic evaluation of varices |
Limitations | Indirect measurement of portal vein pressure. May underestimate presinusoidal PH such as primary biliary cholangitis and metabolic dysfunction-associated steatotic liver disease. May be contraindicated in severe coagulopathy | Limited availability and expertise. Requires further validation. Moderate to deep sedation can cause hemodynamic variations and lead to inaccurate PPG measures |
- Citation: Xie XY, Benmassaoud A. Advances in the diagnosis and management of clinically significant portal hypertension in cirrhosis: A narrative review. World J Hepatol 2025; 17(6): 104761
- URL: https://www.wjgnet.com/1948-5182/full/v17/i6/104761.htm
- DOI: https://dx.doi.org/10.4254/wjh.v17.i6.104761